Management Sciences for Health Applauds President Biden’s Commitment to Vaccine Equity and Global Health Security

Arlington, VA—February 22, 2021—Management Sciences for Health (MSH) welcomes President Biden’s announcement that the United States will contribute $4 billion to COVAX, an international effort to source and distribute COVID-19 vaccines. An initial $2 billion will be donated in 2021, with an additional $2 billion coming over the next two years.

“This U.S. pledge, along with that of a number of other countries, will go a long way in ending the current pandemic and helping to prevent future ones,” said MSH’s Senior External Affairs Officer, Ashley Arabasadi. “We urge every country to make meaningful investments in pandemic preparedness.”

MSH also welcomes President Biden’s plans for “creating an enduring international catalytic financing mechanism for advancing and improving existing bilateral and multilateral approaches to global health security.”

COVAX is co-led by Gavi, known as the Vaccine Alliance, the World Health Organization, and the Coalition for Epidemic Preparedness Innovations (CEPI).